Detection and Characterization of Thrombosis in Humans Using Fibrin-Targeted Positron Emission Tomography and Magnetic Resonance
- PMID: 34656469
- PMCID: PMC8917974
- DOI: 10.1016/j.jcmg.2021.08.009
Detection and Characterization of Thrombosis in Humans Using Fibrin-Targeted Positron Emission Tomography and Magnetic Resonance
Abstract
Objectives: The authors present a novel technique to detect and characterize LAA thrombus in humans using combined positron emission tomography (PET)/cardiac magnetic resonance (CMR) of a fibrin-binding radiotracer, [64Cu]FBP8.
Background: The detection of thrombus in the left atrial appendage (LAA) is vital in the prevention of stroke and is currently performed using transesophageal echocardiography (TEE).
Methods: The metabolism and pharmacokinetics of [64Cu]FBP8 were studied in 8 healthy volunteers. Patients with atrial fibrillation and recent TEEs of the LAA (positive n = 12, negative n = 12) were injected with [64Cu]FBP8 and imaged with PET/CMR, including mapping the longitudinal magnetic relaxation time (T1) in the LAA.
Results: [64Cu]FBP8 was stable to metabolism and was rapidly eliminated. The maximum standardized uptake value (SUVMax) in the LAA was significantly higher in the TEE-positive than TEE-negative subjects (median of 4.0 [interquartile range (IQR): 3.0-6.0] vs 2.3 [IQR: 2.1-2.5]; P < 0.001), with an area under the receiver-operating characteristic curve of 0.97. An SUVMax threshold of 2.6 provided a sensitivity of 100% and specificity of 84%. The minimum T1 (T1Min) in the LAA was 970 ms (IQR: 780-1,080 ms) vs 1,380 ms (IQR: 1,120-1,620 ms) (TEE positive vs TEE negative; P < 0.05), with some overlap between the groups. Logistic regression using SUVMax and T1Min allowed all TEE-positive and TEE-negative subjects to be classified with 100% accuracy.
Conclusions: PET/CMR of [64Cu]FBP8 is able to detect acute as well as older platelet-poor thrombi with excellent accuracy. Furthermore, the integrated PET/CMR approach provides useful information on the biological properties of thrombus such as fibrin and methemoglobin content. (Imaging of LAA Thrombosis; NCT03830320).
Keywords: MRI; PET; atrial fibrillation; fibrin; left atrial appendage; thrombus.
Copyright © 2022 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Funding Support and Author Disclosures Support for this study was provided in part by the following grants from the National Institutes of Health: R01HL109448 (to Drs Caravan and Sosnovik), R01HL141563 (to Dr Sosnovik), R01HL131907 (to Dr Caravan), R01HL131635 (to Dr Mekkaoui), and R01CA218187 (to Dr Catana); and the following grants to the A. A. Martinos Center for Biomedical Imaging: S10RR022976, S10RR019933, P41EB015896. Dr Caravan is an inventor of [64Cu]FBP8, which is patented by Massachusetts General Hospital. Dr Caravan is a founder of and has financial interests in Collagen Medical, LLC, and Factor 1A, LLC, which are developing fibrin-targeted imaging probes. Factor 1A, LLC has a license to the patent covering the probe [64Cu]FBP8 that used in this study. Dr Caravan’s interests were reviewed and are managed by Massachusetts General Hospital and Mass General Brigham in accordance with their conflict of interest policies. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures





Comment in
-
Fibrin-Targeted PET/CMR in Atrial Fibrillation: First Steps Toward Imaging Thrombus Biology.JACC Cardiovasc Imaging. 2022 Mar;15(3):516-518. doi: 10.1016/j.jcmg.2021.09.003. Epub 2021 Oct 13. JACC Cardiovasc Imaging. 2022. PMID: 34656476 No abstract available.
Similar articles
-
Detection of left atrial appendage thrombus by cardiac computed tomography in patients with atrial fibrillation: a meta-analysis.Circ Cardiovasc Imaging. 2013 Mar 1;6(2):185-94. doi: 10.1161/CIRCIMAGING.112.000153. Epub 2013 Feb 13. Circ Cardiovasc Imaging. 2013. PMID: 23406625
-
First-in-human Evaluation of Safety and Dosimetry of [64Cu]FBP8: A fibrin-binding PET Probe.Mol Imaging Biol. 2025 Feb;27(1):99-108. doi: 10.1007/s11307-024-01973-3. Epub 2024 Dec 4. Mol Imaging Biol. 2025. PMID: 39633070
-
Rationale and design of a study exploring the efficacy of once-daily oral rivaroxaban (X-TRA) on the outcome of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation or atrial flutter and a retrospective observational registry providing baseline data (CLOT-AF).Am Heart J. 2015 Apr;169(4):464-71.e2. doi: 10.1016/j.ahj.2014.12.020. Epub 2015 Jan 6. Am Heart J. 2015. PMID: 25819852
-
Left atrial appendage velocity, association with inflammatory indices in non-valvular atrial fibrillation patients.Future Cardiol. 2025 Feb;21(2):103-111. doi: 10.1080/14796678.2025.2458414. Epub 2025 Jan 28. Future Cardiol. 2025. PMID: 39874020
-
PET-CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer.Cochrane Database Syst Rev. 2014 Nov 13;2014(11):CD009519. doi: 10.1002/14651858.CD009519.pub2. Cochrane Database Syst Rev. 2014. PMID: 25393718 Free PMC article.
Cited by
-
Non-invasive in vivo imaging of changes in Collagen III turnover in myocardial fibrosis.Npj Imaging. 2024;2(1):33. doi: 10.1038/s44303-024-00037-z. Epub 2024 Sep 17. Npj Imaging. 2024. PMID: 39301014 Free PMC article.
-
Targeted Molecular Imaging Sheds Light on Bioprosthetic Aortic Valve Thrombosis.JACC Cardiovasc Imaging. 2022 Jun;15(6):1121-1123. doi: 10.1016/j.jcmg.2022.03.025. JACC Cardiovasc Imaging. 2022. PMID: 35680219 Free PMC article. No abstract available.
-
In vivo real-time red blood cell migration and microcirculation flow synergy imaging-surveyed thrombolytic therapy with iron-oxide complexes.Mater Today Bio. 2022 Aug 26;16:100408. doi: 10.1016/j.mtbio.2022.100408. eCollection 2022 Dec. Mater Today Bio. 2022. PMID: 36097598 Free PMC article.
-
Tuning the Properties of Rigidified Acyclic DEDPA2- Derivatives for Application in PET Using Copper-64.Inorg Chem. 2024 Nov 18;63(46):22297-22307. doi: 10.1021/acs.inorgchem.4c04050. Epub 2024 Nov 7. Inorg Chem. 2024. PMID: 39508185 Free PMC article.
-
Delivery of a fibrin-binding hemostatic polymer ameliorates neurovascular damage and neural tissue loss after traumatic brain injury.Sci Adv. 2025 Jul 18;11(29):eadw7425. doi: 10.1126/sciadv.adw7425. Epub 2025 Jul 18. Sci Adv. 2025. PMID: 40680138 Free PMC article.
References
Publication types
MeSH terms
Substances
Associated data
Grants and funding
LinkOut - more resources
Full Text Sources
Medical